BioCardia, Inc. ( BCDA) - Key Metrics
BCDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.13 | -$0.14 | -$0.14 |
| 2026Q1 | $0 | -$0.21 | -$0.15 | -$0.15 |
| 2025Q4 | $0 | -$0.18 | -$0.23 | -$0.23 |
| 2025Q3 | $0 | -$0.24 | -$0.27 | -$0.27 |
| 2025Q2 | $0 | -$0.40 | -$0.33 | -$0.33 |
BCDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.38 |
| 2026Q1 | 0% | -1.44 |
| 2025Q4 | 0% | -1.74 |
| 2025Q3 | 0% | -1.34 |
| 2025Q2 | 0% | -1.22 |
BCDA
Price: $1.02
52 week price:
Earnings Per Share: -0.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 50500
Market Capitalization: 15.5 million